Cargando…
Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Therefore, fighting against such cancer is reasonable. Chemotherapy drugs are sometimes inefficient and often accompanied by undesirable side effects for patients. On the other hand, the emergence of chemoresistant HCC em...
Autores principales: | Heiat, Mohammad, Hashemi Yeganeh, Hamid, Alavian, Seyed Moayed, Rezaie, Ehsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538445/ https://www.ncbi.nlm.nih.gov/pubmed/34679012 http://dx.doi.org/10.3390/toxins13100719 |
Ejemplares similares
-
DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
por: Hashemi Yeganeh, Hamid, et al.
Publicado: (2021) -
Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity
por: Ataee, Mohammad Hossein, et al.
Publicado: (2022) -
Classical and Modern Approaches Used for Viral Hepatitis Diagnosis
por: Heiat, Mohammad, et al.
Publicado: (2014) -
Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review
por: Alavian, Seyed Moayed, et al.
Publicado: (2016) -
How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)